Search

Your search keyword '"Mir Alireza Hoda"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Mir Alireza Hoda" Remove constraint Author: "Mir Alireza Hoda"
164 results on '"Mir Alireza Hoda"'

Search Results

51. Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology

52. Time-lapse video showing 4 days of sprout formation by HUVEC aggregate in fibrin extracellular matrix (ECM) gel in the presence of a P31 spheroid. Images were captured every hour by phase-contrast microscopy. Scale bar: 100 µm

53. Time-lapse video showing 4 days of sprout formation by HUVEC aggregate in fibrin ECM gel in the presence of a SPC111 spheroid. Images were captured every hour by phase-contrast microscopy. Scale bar: 100 µm

54. Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma : An international multicenter study

55. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

56. Activin A: an emerging target for improving cancer treatment?

57. Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma

58. Lungs from polytrauma donors with significant chest trauma can be safely used for transplantation

59. Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup

60. Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo

61. Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery

62. The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization

63. Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors

64. Anesthesia for double lung transplant in a patient with confirmed COVID-19 infection: a case report

65. KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

66. Safety and efficacy of video-assisted thoracoscopic biopsy in patients with interstitial lung disease- a retrospective cohort study

67. Neoadjuvant treatment including immunotherapy followed by curative intent resection in patients with advanced NSCLC: initial institutional experience

69. Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity

70. Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

71. The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma

72. Systemic and local inflammation characteristics in patients with cancer after lung transplantation

74. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro

75. Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging

76. Management of malignant pleural mesothelioma – part 3

77. Management of malignant pleural mesothelioma—part 2: therapeutic approaches

78. Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study

80. 1953P Gender and molecular aspects of targeted therapy recommendations for therapy refractory solid tumours: Data from the real-world precision medicine platform MONDTI

81. New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study

82. Author Correction: Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma

83. P2.06-21 Low Intratumoral Platinum Concentration is Associated with Unfavorable Clinical Outcome in Malignant Pleural Mesothelioma

85. A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma

86. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma

87. Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma

88. Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma

89. Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma

90. Extrapleural Pneumonectomy After Induction Chemotherapy: Perioperative Outcome in 251 Mesothelioma Patients From Three High-Volume Institutions

91. Fibroblast Growth Factor Receptor Inhibition Is Active against Mesothelioma and Synergizes with Radio- and Chemotherapy

92. A critical update on prognostic and predictive biomarkers in malignant pleural mesothelioma

93. Lobar lung transplantation-Is it comparable with standard lung transplantation?

94. EP1.01-82 10 Years Single Center Experience with Resection of the Superior Vena Cava in Locally Advanced Non-Small Cell Lung Cancer

95. P2.15-11 Favorable Long Term Survival After Initially Palliative Resection for a Giant Primary Rib Osteosarcoma with Severe Mediastinal Shifting

96. EP1.17-15 Comparison of Long-Term Outcome of Wedge Resection, Anatomical Segmentectomy and Lobectomy in Stage I-II Non-Small Cell Lung Cancer

97. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma

98. Cell migration or cytokinesis and proliferation? – Revisiting the 'go or grow' hypothesis in cancer cells in vitro

99. Encephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patients

100. The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization

Catalog

Books, media, physical & digital resources